BackFujian Aonong Biological Technology Group Incorporation Limited Overview

Fujian Aonong Biological Technology Group Incorporation Limited Current Assets

Latest current assets for 603363.SS: $3.5B.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$3.48B
↑ 1.61% YoYΔ $55.29M vs prior year quarter

Peer trimmed avg / median

Loading

Fujian Aonong Biological Technology Group Incorporation Limited Current Assets History

Loading

Fujian Aonong Biological Technology Group Incorporation Limited vs. peers: Current Assets Comparison

Loading

Fujian Aonong Biological Technology Group Incorporation Limited Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS) FAQ

Fujian Aonong Biological Technology Group Incorporation Limited posts a current assets of $3.5B as of June 2026. That compares with $3.4B in the prior-year period — up 1.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Fujian Aonong Biological Technology Group Incorporation Limited's current assets was $3.4B. The latest reading is $3.5B — a 1.6% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Fujian Aonong Biological Technology Group Incorporation Limited's financial statement story. At $3.5B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 603363.SS's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Fujian Aonong Biological Technology Group Incorporation Limited's other metric pages and overview cover the third.